Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol

Bradley A. Arrick, Murray Korc, Rik Derynck

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Transforming growth factor (TGF)-β is a potent regulator of many cell functions and a growth inhibitor for mammary epithelial cells. We now know of three highly homologous members of the human TGF-β gene family. We have studied the expression of TGF-β1, -β2, and -β3 mRNA in four human breast cancer cell lines. Using the RNase protection assay, we have detected mRNA expression of TGF-β1, -β2, and -β3 by T-47D tells, TGF-β1 and -β3 by ZR-75-1 cells, and TGF-β1 by MCF-7 cells. Treatment of these estrogen receptor-positive cells with 10 nM estradiol for 48 h resulted in decreased mRNA levels of TGF-β2 and -β3 but did not affect mRNA levels of TGF-β1. Expression of TGF-β1 and -β2 mRNA by an estrogen receptor-negative cell line, MDA-MB-231, was not changed by estradiol treatment. Treatment of cells with the antiestrogen tamoxifen (1 μM) did not significantly alter mRNA levels for any of the three TGF-β species. We have further determined that estradiol treatment of T-47D was associated with diminished secretion of TGF-β into the medium. Both TGF-β1 and -β2 inhibited the proliferation of MCF-7 cells, and neither protein affected the growth of T-47D cells. TGF-β1 was at least 10-fold more potent than TGF-β2 at inhibiting the growth of MCF-7 cells.

Original languageEnglish (US)
Pages (from-to)299-303
Number of pages5
JournalCancer Research
Volume50
Issue number2
StatePublished - Jan 15 1990
Externally publishedYes

Fingerprint

Transforming Growth Factors
Estradiol
Breast Neoplasms
Cell Line
Messenger RNA
MCF-7 Cells
Estrogen Receptors
Growth Inhibitors
Estrogen Receptor Modulators
Tamoxifen
Ribonucleases
Growth
Breast

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. / Arrick, Bradley A.; Korc, Murray; Derynck, Rik.

In: Cancer Research, Vol. 50, No. 2, 15.01.1990, p. 299-303.

Research output: Contribution to journalArticle

@article{eb781623b5cc4851a4bab72c75a8b7bc,
title = "Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol",
abstract = "Transforming growth factor (TGF)-β is a potent regulator of many cell functions and a growth inhibitor for mammary epithelial cells. We now know of three highly homologous members of the human TGF-β gene family. We have studied the expression of TGF-β1, -β2, and -β3 mRNA in four human breast cancer cell lines. Using the RNase protection assay, we have detected mRNA expression of TGF-β1, -β2, and -β3 by T-47D tells, TGF-β1 and -β3 by ZR-75-1 cells, and TGF-β1 by MCF-7 cells. Treatment of these estrogen receptor-positive cells with 10 nM estradiol for 48 h resulted in decreased mRNA levels of TGF-β2 and -β3 but did not affect mRNA levels of TGF-β1. Expression of TGF-β1 and -β2 mRNA by an estrogen receptor-negative cell line, MDA-MB-231, was not changed by estradiol treatment. Treatment of cells with the antiestrogen tamoxifen (1 μM) did not significantly alter mRNA levels for any of the three TGF-β species. We have further determined that estradiol treatment of T-47D was associated with diminished secretion of TGF-β into the medium. Both TGF-β1 and -β2 inhibited the proliferation of MCF-7 cells, and neither protein affected the growth of T-47D cells. TGF-β1 was at least 10-fold more potent than TGF-β2 at inhibiting the growth of MCF-7 cells.",
author = "Arrick, {Bradley A.} and Murray Korc and Rik Derynck",
year = "1990",
month = "1",
day = "15",
language = "English (US)",
volume = "50",
pages = "299--303",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol

AU - Arrick, Bradley A.

AU - Korc, Murray

AU - Derynck, Rik

PY - 1990/1/15

Y1 - 1990/1/15

N2 - Transforming growth factor (TGF)-β is a potent regulator of many cell functions and a growth inhibitor for mammary epithelial cells. We now know of three highly homologous members of the human TGF-β gene family. We have studied the expression of TGF-β1, -β2, and -β3 mRNA in four human breast cancer cell lines. Using the RNase protection assay, we have detected mRNA expression of TGF-β1, -β2, and -β3 by T-47D tells, TGF-β1 and -β3 by ZR-75-1 cells, and TGF-β1 by MCF-7 cells. Treatment of these estrogen receptor-positive cells with 10 nM estradiol for 48 h resulted in decreased mRNA levels of TGF-β2 and -β3 but did not affect mRNA levels of TGF-β1. Expression of TGF-β1 and -β2 mRNA by an estrogen receptor-negative cell line, MDA-MB-231, was not changed by estradiol treatment. Treatment of cells with the antiestrogen tamoxifen (1 μM) did not significantly alter mRNA levels for any of the three TGF-β species. We have further determined that estradiol treatment of T-47D was associated with diminished secretion of TGF-β into the medium. Both TGF-β1 and -β2 inhibited the proliferation of MCF-7 cells, and neither protein affected the growth of T-47D cells. TGF-β1 was at least 10-fold more potent than TGF-β2 at inhibiting the growth of MCF-7 cells.

AB - Transforming growth factor (TGF)-β is a potent regulator of many cell functions and a growth inhibitor for mammary epithelial cells. We now know of three highly homologous members of the human TGF-β gene family. We have studied the expression of TGF-β1, -β2, and -β3 mRNA in four human breast cancer cell lines. Using the RNase protection assay, we have detected mRNA expression of TGF-β1, -β2, and -β3 by T-47D tells, TGF-β1 and -β3 by ZR-75-1 cells, and TGF-β1 by MCF-7 cells. Treatment of these estrogen receptor-positive cells with 10 nM estradiol for 48 h resulted in decreased mRNA levels of TGF-β2 and -β3 but did not affect mRNA levels of TGF-β1. Expression of TGF-β1 and -β2 mRNA by an estrogen receptor-negative cell line, MDA-MB-231, was not changed by estradiol treatment. Treatment of cells with the antiestrogen tamoxifen (1 μM) did not significantly alter mRNA levels for any of the three TGF-β species. We have further determined that estradiol treatment of T-47D was associated with diminished secretion of TGF-β into the medium. Both TGF-β1 and -β2 inhibited the proliferation of MCF-7 cells, and neither protein affected the growth of T-47D cells. TGF-β1 was at least 10-fold more potent than TGF-β2 at inhibiting the growth of MCF-7 cells.

UR - http://www.scopus.com/inward/record.url?scp=0025101596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025101596&partnerID=8YFLogxK

M3 - Article

C2 - 2295070

AN - SCOPUS:0025101596

VL - 50

SP - 299

EP - 303

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 2

ER -